Stockscreener 앱 받기
2.92
7.28%
0.24
전일 마감가:
$2.68
열려 있는:
$2.68
하루 거래량:
26,514
Relative Volume:
0.03
시가총액:
$3.09M
수익:
$49,300
순이익/손실:
$-6.27M
주가수익비율:
-0.3212
EPS:
-9.09
순현금흐름:
$-5.38M
1주 성능:
+7.28%
1개월 성능:
+6.48%
6개월 성능:
-60.62%
1년 성능:
-98.15%
1일 변동 폭
$2.63
$2.93
1주일 범위
$2.55
$2.93
52주 변동 폭
$2.3401
$224.37
Aclarion Inc Stock (ACON) Company Profile
명칭
Aclarion Inc
전화
833 275 2266
주소
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
2.93 | 2.83M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
187.05 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.62 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.71 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
82.47 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.86 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Aclarion Inc 주식(ACON)의 최신 뉴스
Bank Watch: Does Five Below Inc stock have upside surprise potentialMarket Activity Recap & Safe Entry Momentum Tips - baoquankhu1.vn
Retail Trends: Whats next for CalciMedica Inc stock2025 Sector Review & Technical Entry and Exit Tips - baoquankhu1.vn
ACON PE Ratio & Valuation, Is ACON Overvalued - Intellectia AI
Activity Recap: Is Tidewater Inc forming a breakout patternWeekly Market Outlook & Weekly Top Stock Performers List - baoquankhu1.vn
ACON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Volatility Watch: Is Aclarion Inc still a buy after recent gainsTrade Risk Summary & High Return Stock Watch Alerts - baoquankhu1.vn
Trading Recap: Whats the outlook for Aclarion Inc Equity Warrants sectorJuly 2025 Summary & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Investor Mood: Is Aclarion Inc Equity Warrant still a buy after recent gains - baoquankhu1.vn
Market Wrap: Is Aclarion Inc Equity Warrant stock undervalued right now2025 Big Picture & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Can Aclarion Inc. Equity Warrant stock continue upward trend2025 Key Lessons & Safe Entry Momentum Stock Tips - mfd.ru
US Market Wrap: Should I hold or sell Aclarion Inc. Equity Warrant now2025 Short Interest & Stepwise Entry and Exit Trade Signals - mfd.ru
Is Aclarion Inc. stock positioned for long term growthWeekly Earnings Recap & Consistent Income Trade Ideas - mfd.ru
ACON Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ACON Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Can Aclarion Inc. weather a recessionNew Guidance & Verified Stock Trade Ideas - mfd.ru
What are Aclarion Inc.’s earnings expectationsWeekly Stock Report & Reliable Price Action Trade Plans - mfd.ru
Earnings Beat: Is TriSalus Life Sciences Inc Equity Warrant a strong growth stock2025 Growth vs Value & Short-Term Trading Alerts - baoquankhu1.vn
What’s the outlook for Aclarion Inc. Equity Warrant’s sectorWeekly Investment Report & Low Drawdown Trading Strategies - mfd.ru
NeuroOne Medical Technologies (NASDAQ:NMTC) versus Aclarion (NASDAQ:ACON) Head to Head Contrast - Defense World
How does Aclarion Inc. Equity Warrant correlate with NasdaqWeekly Investment Summary & Daily Chart Pattern Signals - mfd.ru
How does Aclarion Inc. compare to its peersInsider Selling & Precise Trade Entry Recommendations - mfd.ru
Market Leaders: Whats the outlook for Aclarion Inc Equity Warrants sectorWeekly Profit Report & Short-Term High Return Ideas - baoquankhu1.vn
Analyst Upgrade: Does SPOT have declining or rising EPSOil Prices & Community Trade Idea Sharing - baoquankhu1.vn
Aclarion secures $10.4M for back-pain diagnostic technology - BizWest
Aclarion Publishes 2026 Shareholder Letter from the Chairman - The Globe and Mail
Aclarion, Inc. Announces Strong Financial Position and Path to CLARITY Trial Milestones Ahead of 2026 - Quiver Quantitative
No new funding planned as Aclarion awaits back pain trial data in 2026 - Stock Titan
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes - Asianet Newsable
Aclarion CEO Outlines 2026 Execution Plan Focused on Reimbursement and Adoption - intellectia.ai
Aclarion CEO Bets On Bigger AI MedTech’s Playbook To Revive Sagging Stock - Stocktwits
Aclarion partners with Source Healthcare to expand Nociscan availability By Investing.com - Investing.com Nigeria
Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation - Ortho Spine News
Aclarion Expands Nociscan Availability in Greater Los Angeles - Intellectia AI
Aclarion partners with Source Healthcare to expand Nociscan availability - Investing.com
Aclarion Expands Nociscan Availability in Greater Los Angeles Area Through Partnership with Source Healthcare - Quiver Quantitative
LA pain clinic adds Aclarion’s noninvasive alternative to spinal injections - stocktitan.net
Healthcare Stocks To Keep An Eye OnJanuary 8th - MarketBeat
Is Aclarion Inc. Equity Warrant stock suitable for long term investingJuly 2025 Volume & Low Drawdown Investment Strategies - mfd.ru
Investment Recap: What is Aclarion Inc Equity Warrants 5 year growth outlookWatch List & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Will Aclarion Inc. Equity Warrant outperform tech stocksCPI Data & Weekly Setup with ROI Potential - mfd.ru
Short Interest in Aclarion, Inc. (NASDAQ:ACON) Rises By 379.3% - Defense World
Investment Review: How do insiders feel about Nova Minerals Limited Depositary ReceiptJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - baoquankhu1.vn
Aug Reactions: What is Aclarion Inc Equity Warrants 5 year growth outlookJuly 2025 Update & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Growth Report: Will KVUE outperform tech stocks2025 Buyback Activity & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Weekly Trades: Can FNGD ride the EV waveWeekly Stock Recap & Smart Money Movement Tracker - baoquankhu1.vn
S P Trends: Will Aclarion Inc stock recover after earningsWeekly Stock Report & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Aclarion to enroll around 25% of patients in CLARITY trial by Q2 - MSN
Earnings Update: Is Aclarion Inc Equity Warrant stock undervalued right nowBear Alert & Free Reliable Trade Execution Plans - baoquankhu1.vn
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update - Defense World
Levels Update: Can FENC scale operations efficientlyWeekly Volume Report & Real-Time Buy Zone Alerts - baoquankhu1.vn
Pharma News: Is Perpetua Resources Corp forming a bullish divergenceWeekly Trading Summary & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Aclarion Inc (ACON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.50%
자본화:
|
볼륨(24시간):